Neuroscience Focus Areas:
Our other therapy areas

    • {%itemName%}
        {%brandMenuItems%}
    • {%itemName%} {%arrowSpan%}
        {%subBrandMenuItems%}
    • {%itemName%} {%arrowSpan%}
        {%productMenuItems%}
    • {%itemKeyName%} {%itemBadges%} {%arrowSpan%}
      {%selfProduct%}
    • {%itemName%}
      • {%countries%}
    • {%allMenuItem%}
      • {%languages%}

      • This website is for UK Healthcare Professionals only

      This series of podcasts provides peer-to-peer insights on best
      practice around the initiation and use of suitable therapy for
      people with Complex/Advanced Parkinson’s disease in the UK.

      Meet the podcasters

      The podcast series host is Dr Donald Grosset, Consultant Neurologist specialising in Parkinson’s disease and movement disorders at the Institute of Neurological Sciences, Queen Elizabeth University Hospital, Glasgow, Honorary Professor of Neurology at the University of Glasgow, and Clinical Director for the UK Parkinson’s Excellence Network.

      Dr Alastair Noyce is Consultant Neurologist at Barts Health NHS Trust and Reader in Neurology and Neuroepidemiology at the Wolfson Institute of Population Health, Queen Mary University of London, with interests in the early identification of Parkinson’s disease and provision of movement disorders services.

      Dr Patrick Dubois is Consultant Gastroenterologist, Endoscopist, and Physician at King’s College Hospital in London, where he runs the percutaneous endoscopic gastro-jejunostomy (PEG-J) placement service for patients initiating treatment with DUODOPA.

      Dr Michael Bonello is Consultant Neurologist at The Walton Centre NHS Foundation Trust in Liverpool and Honorary Lecturer at the University of Liverpool, with a special interest in movement disorders and genetic conditions.

      Lucy Mooney is Lead Movement Disorder Nurse Specialist for the Advanced Treatment Service for Parkinson’s at Southmead Hospital in Bristol, where she is responsible for managing the nursing team that works as part of the DUODOPA Service.

      Janie is a retired NHS nurse who was diagnosed with Parkinson’s disease 14 years ago and has been treated with DUODOPA for Complex/Advanced Parkinson’s for the last 3 years. She is married, with four daughters and several grandchildren.

      Episode 1

      This is a promotional podcast created by AbbVie and is intended for UK healthcare professionals only. Prescribing Information and Adverse Event reporting information for any AbbVie products mentioned in this podcast is available at the top of this page. Dr Alastair Noyce shares expert advice on establishing a Parkinson’s disease advanced therapy service and identifying the right treatment for the right patient. 

      {{currentVideo.name}}

      {{currentVideo.description}}

      {{currentVideo.long_description}}

      Episode 2

      This is a promotional podcast created by AbbVie and is intended for UK healthcare professionals only. Prescribing Information and Adverse Event reporting information for any AbbVie products mentioned in this podcast is available at the top of this page. Dr Patrick Dubois discusses best practices when delivering PEG-J placement services for patients initiating device-aided therapy with DUODOPA.  

      {{currentVideo.name}}

      {{currentVideo.description}}

      {{currentVideo.long_description}}

      Episode 3

      This is a promotional podcast created by AbbVie and is intended for UK healthcare professionals only. Prescribing Information and Adverse Event reporting information for any AbbVie products mentioned in this podcast is available at the top of this page. Dr Michael Bonello talks about the burden of dyskinesia for people with Complex/Advanced Parkinson’s disease and implications for device-aided therapy selection. 

      {{currentVideo.name}}

      {{currentVideo.description}}

      {{currentVideo.long_description}}

      Episode 4

      This is a promotional podcast created by AbbVie and is intended for UK healthcare professionals only. Prescribing Information and Adverse Event reporting information for any AbbVie products mentioned in this podcast is available at the top of this page. Lucy Mooney talks to Janie about everyday life with DUODOPA and the impact it has on living with Complex/Advanced Parkinson’s disease. 

      {{currentVideo.name}}

      {{currentVideo.description}}

      {{currentVideo.long_description}}

      References

      Episode 1

      1. Antonini A, et al. Curr Med Res Opin 2018;34(12):2063–73
      2. Dijk JM, et al. J Parkinsons Dis 2020;10:S65–73.
      Episode 2
      1. DUODOPA (levodopa/carbidopa intestinal gel) Summary of Product Characteristics. Available at: https://www.medicines.org.uk/emc/medicine/20786. Accessed August 2022.
      Episode 3
      1. Amantadine Summary of Product Characteristics. Available at: https://www.medicines.org.uk/emc/product/12068/smpc. Accessed August 2022.
      2. Antonini A, et al. Curr Med Res Opin 2018;34(12):2063–73.
      3. Dijk JM, et al. J Parkinsons Dis 2020;10:S65–73.
      4. DUODOPA (levodopa/carbidopa intestinal gel) Summary of Product Characteristics. Available at: https://www.medicines.org.uk/emc/medicine/20786. Accessed August 2022.
      5. Fasano A et al. Mov Disord 2021;36(8):1853-62.
      6. Nyholm D et al. AAPS Journal 2013;15(2):316-23.
      7. Olanow et al. Neurology 2006;2(7);382-92.
      8. Schrag A and Quinn N. Brain 2000;123:2297-305.
      9. Sharma JC and Vassallo M. Neurodegen Dis Manage 2014;4(4):309-16.
      10. Thanvi BR and Lo TCN. Postgrad Med J 2004;80:452-8.
      11. Verhagen Metman L et al. Neurology 1998;50:1323-6.
      Episode 4
      1. DUODOPA (levodopa/carbidopa intestinal gel) Summary of Product Characteristics. Available at: https://www.medicines.org.uk/emc/medicine/20786. Accessed August 2022.
      DUODOPA PRESCRIBING INFORMATION

       

      Adverse events should be reported. Reporting forms and information can be found at yellowcard.mhra.gov.uk.

      Adverse events should also be reported to AbbVie on [email protected] 

       

      UK-DUOD-220170. Date of preparation: August 2022.